Back To Schedule
Wednesday, March 11 • 11:15am - 12:00pm
Explore Innovative Deal Constructs and Risk-Sharing Structures for Licensing and Acquisition Deals

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Review the risks and hurdles to watch out for from an accounting point of view
  • Evaluate how robust your governance structure should be before you start to control the development of an options-based asset
  • Discuss the best ways to structure options agreements and how to minimize exposure to your P&L while ensuring the requisite controls needed

avatar for Jay Parrish

Jay Parrish

Chief Business Officer, VIR BIOTECHNOLOGY
avatar for Neil Abdollahian, M.S., M.B.A.

Neil Abdollahian, M.S., M.B.A.

Chief Business Officer, CIDARA THERAPEUTICS
Neil Abdollahian, M.S. MBA, has 20 years of corporate strategy, partnering and M&A experience in the biopharmaceutical industry and currently leads Cidara’s corporate development strategy and execution.Mr. Abdollahian’s career has been focused on building companies through strategic... Read More →
avatar for Matt Panuwat

Matt Panuwat

Chief Business Officer, ORIC PHARMACEUTICALS
Prior to joining ORIC recently as Chief Business Officer, Matt was Senior Vice President of Business Development at Prothena, where he led partnership activities and established the company’s global research & development collaboration with Celgene. Prior to Prothena, he was Head... Read More →

Wednesday March 11, 2020 11:15am - 12:00pm
C.A. Thayer